| Pharmaceutical Information |
| Drug Name |
Lomitapide |
| Drug ID |
BADD_D01311 |
| Description |
Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor used in homozygous familial hypercholesterolemia (HoFH) patients. It is marketed under the name Juxtapid (R). |
| Indications and Usage |
Used in homozygous familial hypercholesterolemia (HoFH) patients to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C). |
| Marketing Status |
Prescription |
| ATC Code |
C10AX12 |
| DrugBank ID |
DB08827
|
| KEGG ID |
D09637
|
| MeSH ID |
C473731
|
| PubChem ID |
9853053
|
| TTD Drug ID |
D0H8VY
|
| NDC Product Code |
Not Available |
| Synonyms |
BMS201038 | BMS-201038 | BMS 201038 | lomitapide | Juxtapid | AEGR 733 | AEGR733 | AEGR-733 |
|
| Chemical Information |
| Molecular Formula |
C39H37F6N3O2 |
| CAS Registry Number |
182431-12-5 |
| SMILES |
C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C
(=O)NCC(F)(F)F |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
|
|
| ADRs Induced by Drug |
|
|
